{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T19:00:40Z","timestamp":1785265240894,"version":"3.55.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000001","name":"Alberta Cancer Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004339","name":"Sanofi-Aventis US LLC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.jtct.2025.09.042","type":"journal-article","created":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T22:39:30Z","timestamp":1759012770000},"page":"191.e1-191.e12","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Cytokines Induced by Antithymocyte Globulin in Transplantation Conditioning and Associated Infusional Side Effects"],"prefix":"10.1016","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7884-9122","authenticated-orcid":false,"given":"Jan","family":"Storek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Dookie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rutvij","family":"Khanolkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2139-5174","authenticated-orcid":false,"given":"Megan","family":"Kinzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riley","family":"Ngo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamid","family":"Ghazal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-4600-3359","authenticated-orcid":false,"given":"Sofia","family":"Leuchter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8918-6598","authenticated-orcid":false,"given":"Robert","family":"Puckrin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Poonam","family":"DharmaniKhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faisal M.","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtct.2025.09.042_bib0001","doi-asserted-by":"crossref","first-page":"e100","DOI":"10.1016\/S2352-3026(19)30220-0","volume":"7","author":"Walker","year":"2020","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.jtct.2025.09.042_bib0002","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.bbmt.2005.12.034","article-title":"Thymoglobulin prevents chronic graft-versus-host disease, chronic lung dysfunction, and late transplant-related mortality: long-term follow-up of a randomized trial in patients undergoing unrelated donor transplantation","volume":"12","author":"Bacigalupo","year":"2006","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2025.09.042_bib0003","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.1002\/cncr.30540","article-title":"Optimal dose of rabbit thymoglobulin in conditioning regimens for unmanipulated, haploidentical, hematopoietic stem cell transplantation: long-term outcomes of a prospective randomized trial","volume":"123","author":"Chang","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.jtct.2025.09.042_bib0004","doi-asserted-by":"crossref","first-page":"320","DOI":"10.5500\/wjt.v5.i4.320","article-title":"Perioperative effects of high doses of intraoperative thymoglobulin induction in liver transplantation","volume":"5","author":"De Pietri","year":"2015","journal-title":"World J Transplant"},{"key":"10.1016\/j.jtct.2025.09.042_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtct.2022.02.016","volume":"28","author":"Knaus","year":"2022","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jtct.2025.09.042_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.trim.2023.101830","article-title":"Cytokine profiling during conditioning in haploidentical stem cell transplantation and its prognostic impact on early transplant outcomes","volume":"78","author":"Li","year":"2023","journal-title":"Transpl Immunol"},{"key":"10.1016\/j.jtct.2025.09.042_bib0007","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s12032-014-0465-y","article-title":"Outcomes of peripheral blood stem cell transplantation patients from HLA-mismatched unrelated donor with antithymocyte globulin (ATG)-Thymoglobulin versus ATG-Fresenius: a single-center study","volume":"32","author":"Huang","year":"2015","journal-title":"Med Oncol"},{"key":"10.1016\/j.jtct.2025.09.042_bib0008","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1007\/s00277-024-05724-w","article-title":"Comparison of rabbit ATLG and ATG for GVHD prophylaxis in hematological malignancies with haploidentical hematopoietic stem cell transplantation","volume":"103","author":"Tian","year":"2024","journal-title":"Ann Hematol"},{"key":"10.1016\/j.jtct.2025.09.042_bib0009","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1046\/j.1365-2141.1998.01047.x","article-title":"The incidence and significance of fevers during treatment with antithymocyte globulin for aplastic anaemia","volume":"103","author":"Dearden","year":"1998","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtct.2025.09.042_bib0010","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1188\/04.CJON.377-382","article-title":"Management of patients receiving antithymocyte globulin for aplastic anemia and myelodysplastic syndrome","volume":"8","author":"Bevans","year":"2004","journal-title":"Clin J Oncol Nurs"},{"key":"10.1016\/j.jtct.2025.09.042_bib0011","unstructured":"sanofi-aventis Canada Inc. Thymoglobulin. Product monograph. 2016. Available at:https:\/\/www.sanofi.com\/assets\/countries\/canada\/docs\/products\/prescription-products\/thymoglobulin-en.pdf. Accessed August 28, 2021."},{"key":"10.1016\/j.jtct.2025.09.042_bib0012","article-title":"Hematopoietic cell transplant outcomes after myeloablative conditioning with fludarabine, busulfan, low-dose total body irradiation, and rabbit antithymocyte globulin","author":"Ousia","year":"202034","journal-title":"Clin Transplant"},{"key":"10.1016\/j.jtct.2025.09.042_bib0013","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/sj.bmt.1705295","article-title":"Differential effect of conditioning regimens on cytokine responses during allogeneic stem cell transplantation","volume":"37","author":"Andersen","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2025.09.042_bib0014","doi-asserted-by":"crossref","DOI":"10.1111\/petr.13694","article-title":"Antithymocyte globulin in pediatric allogeneic hematopoietic stem cell transplantation: infusion time and tolerability","volume":"24","author":"Sevrin","year":"2020","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.jtct.2025.09.042_bib0015","doi-asserted-by":"crossref","first-page":"24S","DOI":"10.1016\/S0041-1345(97)80006-1","article-title":"Pharmacokinetics, foreign protein immune response, cytokine release, and lymphocyte subsets in patients receiving thymoglobuline and immunosuppression","volume":"29","author":"Guttmann","year":"1997","journal-title":"Transplant Proc"},{"key":"10.1016\/j.jtct.2025.09.042_bib0016","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1016\/j.bbmt.2020.05.001","article-title":"Risk factors for graft-versus-host disease in haploidentical hematopoietic cell transplantation using post-transplant cyclophosphamide","volume":"26","author":"Im","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2025.09.042_bib0017","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.bbmt.2018.12.758","article-title":"ASTCT Consensus Grading for cytokine release syndrome and neurologic toxicity associated with immune effector cells","volume":"25","author":"Lee","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2025.09.042_bib0018","first-page":"825","article-title":"1994 Consensus Conference on Acute GVHD Grading","volume":"15","author":"Przepiorka","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2025.09.042_bib0019","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.bbmt.2014.12.001","article-title":"National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report","volume":"21","author":"Jagasia","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2025.09.042_bib0020","doi-asserted-by":"crossref","first-page":"3664","DOI":"10.1182\/blood-2014-01-552984","article-title":"Validation and refinement of the Disease Risk Index for allogeneic stem cell transplantation","volume":"123","author":"Armand","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2025.09.042_bib0021","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1182\/bloodadvances.2018030247","article-title":"Antirelapse effect of pretransplant exposure to rabbit antithymocyte globulin","volume":"3","author":"Dabas","year":"2019","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtct.2025.09.042_bib0022","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtct.2024.12.024","article-title":"Impact of underlying disease and total body irradiation on the incidence of graft-versus-host disease after allogeneic hematopoietic cell transplantation","volume":"31","author":"Puckrin","year":"2025","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jtct.2025.09.042_bib0023","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1056\/NEJMra2026131","article-title":"Cytokine storm","volume":"383","author":"Fajgenbaum","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtct.2025.09.042_bib0024","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s40164-020-00171-5","article-title":"Macrophage, the potential key mediator in CAR-T related CRS","volume":"9","author":"Hao","year":"2020","journal-title":"Exp Hematol Oncol"},{"key":"10.1016\/j.jtct.2025.09.042_bib0025","doi-asserted-by":"crossref","first-page":"3804","DOI":"10.1158\/1078-0432.CCR-22-0822","article-title":"Comprehensive serum proteome profiling of cytokine release syndrome and immune effector cell-associated neurotoxicity syndrome patients with B-cell ALL receiving CAR T19","volume":"28","author":"Diorio","year":"2022","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jtct.2025.09.042_bib0026","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1080\/1744666X.2021.1847084","article-title":"Coronavirus disease 2019: investigational therapies in the prevention and treatment of hyperinflammation","volume":"16","author":"Amigues","year":"2020","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.jtct.2025.09.042_bib0027","doi-asserted-by":"crossref","first-page":"3675","DOI":"10.1182\/blood-2008-01-130146","article-title":"Rabbit ATG but not horse ATG promotes expansion of functional CD4+CD25highFOXP3+ regulatory T cells in vitro","volume":"111","author":"Feng","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2025.09.042_bib0028","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1097\/00007890-198903000-00018","article-title":"Evidence of involvement of tumor necrosis factor in adverse reactions during treatment of kidney allograft rejection with antithymocyte globulin","volume":"47","author":"Debets","year":"1989","journal-title":"Transplantation"},{"key":"10.1016\/j.jtct.2025.09.042_bib0029","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1097\/00007890-199510150-00012","article-title":"Antithymocyte globulin preparations after heart transplantation. Cytokine responses in vivo and in vitro","volume":"60","author":"Grant","year":"1995","journal-title":"Transplantation"},{"key":"10.1016\/j.jtct.2025.09.042_bib0030","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1038\/s41409-022-01694-7","article-title":"Rates and predictors of infusion-related reactions in patients receiving standard versus prolonged infusion of rabbit anti-thymocyte globulin for hematopoietic stem cell transplantation, a retrospective analysis","volume":"57","author":"Al Saleh","year":"2022","journal-title":"Bone Marrow Transplant"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636725014757?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636725014757?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:23:32Z","timestamp":1771374212000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636725014757"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S2666636725014757"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2025.09.042","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cytokines Induced by Antithymocyte Globulin in Transplantation Conditioning and Associated Infusional Side Effects","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2025.09.042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of the American Society for Transplantation and Cellular Therapy.","name":"copyright","label":"Copyright"}]}}